KHALED NASR Net Worth - Insider Trades and Bio as of Jun 9, 2026

BRZEBraze, Inc.SEC CIK: 0001276600

Estimated Net Worth

Last Updated: May 19, 2026 02:57 AM EST

Transaction Summary

Total Transactions60

Buy-Sell Ratio1.00

Buy Transactions11

Sell Transactions11

Transaction Volume

Total Volume-$244.27M

Net Volume$266.60M

Buy Volume$11.16M

Sell Volume-$255.44M

Trade Analysis

AVG Trade Size-$4.07M

Largest Trade$3.00M

Most Active MonthFeb

Most Active Year2014

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Khaled Nasr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORGENTECH INC, AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., Invuity, Inc., Trius Therapeutics Inc, PMV Pharmaceuticals, Inc., GLAUKOS Corp, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics Inc, and Transcept Pharmaceuticals Inc.

Holdings & Transactions

BRZEbraze, inc.

Updated: Feb 09, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 09, 2022	3.39M	Options	—	Feb 08	View
From 4	-0.25	1.13M	$61.42	-$69.40M	Nov 23, 2021	3.39M	Sale	—	Nov 19	View
From 3	—	—	—	—	Nov 16, 2021	—	—	—	—	View

DOCSdoximity, inc.

Updated: Dec 06, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.33	4.23M	—	—	Dec 06, 2021	8.69M	Options	—	Dec 02	View
From 4	-0.25	4.23M	—	—	Nov 15, 2021	12.92M	Options	—	Nov 12	View
From 4	-0.20	4.29M	$24.57	-$105.39M	Jun 28, 2021	17.16M	Sale	—	Jun 28	View
From 3	—	—	—	—	Jun 23, 2021	—	—	—	—	View

PMVPpmv pharmaceuticals, inc.

Updated: Jul 14, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.09	471.77K	—	—	Jul 14, 2021	4.50M	Disposition	—	Jul 13	View
From 4	-0.09	498.55K	—	—	May 12, 2021	4.97M	Disposition	—	May 10	View
From 4	-0.15	997.11K	—	—	Mar 25, 2021	5.47M	Disposition	—	Mar 24	View
From 4/A	0.01	55.55K	$18.00	—	Oct 02, 2020	6.47M	Purchase	—	Sep 25 - 29	View
From 4	0.01	55.00K	$18.00	$990.00K	Sep 29, 2020	6.52M	Purchase	—	Sep 25 - 29	View
From 3	—	—	—	—	Sep 24, 2020	—	—	—	—	View

avedro inc

Updated: Nov 25, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	2.75M	—	—	Nov 25, 2019	—	Disposition	—	Nov 21	View
From 4	—	—	—	—	Feb 19, 2019	2.74M	Options	—	Feb 19	View
From 3	—	—	—	—	Feb 13, 2019	101.61K	—	—	—	View

RSLSobalon therapeutics inc

Updated: Aug 08, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.12	43.75K	$4.00	$100.00K	Aug 08, 2019	398.97K	Purchase	—	Aug 06	View
From 4	0.45	1.10M	$1.82	$2.00M	Aug 27, 2018	3.55M	Purchase	—	Aug 23	View
From 4	—	—	—	—	Oct 12, 2016	2.45M	Options	—	Oct 12	View
From 3	—	—	—	—	Oct 05, 2016	—	—	—	—	View

VEROvenus concept inc.

Updated: Nov 12, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Nov 12, 2019	658.66K	Options	—	Nov 07	View
From 4	—	4.29M	$0.47	$2.00M	Aug 22, 2019	4.29M	Purchase	—	Aug 20	View
From 4	0.60	2.00M	$1.50	$3.00M	Aug 13, 2018	5.36M	Purchase	—	Aug 09	View
From 4	—	—	$7.00	—	Oct 17, 2017	3.36M	Options	—	Oct 16	View
From 4	—	—	—	—	Oct 13, 2017	—	Acq/Dis	—	Oct 11	View
From 3	—	—	—	—	Oct 11, 2017	—	—	—	—	View

EIGReiger biopharmaceuticals, inc.

Updated: Oct 22, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.15	237.26K	$12.06	-$2.86M	Oct 22, 2018	1.36M	Sale	—	Oct 18	View
From 3	—	—	—	—	Mar 31, 2016	1.60M	—	—	—	View

invuity, inc.

Updated: Jun 22, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.05	49.30K	—	—	Jun 22, 2015	1.08M	Options	—	Jun 18	View
From 3	—	—	—	—	Jun 11, 2015	—	—	—	—	View

GKOSglaukos corp

Updated: Jun 30, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jun 30, 2015	2.60M	Options	—	Jun 30	View
From 3	—	—	—	—	Jun 24, 2015	—	—	—	—	View

KALVcarbylan therapeutics, inc.

Updated: Apr 14, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.21	810.00K	$5.00	—	Apr 14, 2015	4.62M	Purchase	—	Apr 14	View
From 3	—	—	—	—	Apr 08, 2015	—	—	—	—	View

marketo, inc.

Updated: Jun 02, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.72	124.48K	$24.31	-$3.01M	Jun 02, 2014	49.27K	Sale	—	May 29 - 30	View
From 4	-0.17	848.00K	—	—	May 30, 2014	4.04M	Disposition	—	May 28	View
From 4	-0.39	10.00K	$24.01	-$240.09K	May 22, 2014	15.60K	Sale	—	May 20 - 21	View
From 4	-0.37	15.00K	$22.96	-$344.43K	May 20, 2014	25.60K	Sale	—	May 16	View
From 4	-1.00	34.46K	$24.27	-$836.43K	May 15, 2014	—	Sale	—	May 13 - 14	View
From 4	-0.15	848.00K	—	—	May 14, 2014	4.95M	Disposition	—	May 12	View
From 4	-0.62	24.42K	$41.96	-$1.02M	Mar 03, 2014	15.00K	Sale	—	Feb 27 - 28	View
From 4	-0.62	33.05K	$40.33	-$1.33M	Feb 28, 2014	20.65K	Sale	—	Feb 26	View
From 4	-0.19	1.35M	—	—	Feb 27, 2014	5.85M	Disposition	—	Feb 25	View
From 4	-1.00	4.35K	$40.70	-$177.04K	Feb 18, 2014	—	Sale	—	Feb 13	View
From 4	-0.06	451.49K	—	—	Feb 14, 2014	7.21M	Disposition	—	Feb 12	View
From 4	-0.21	2.08M	$33.99	-$70.82M	Sep 18, 2013	7.66M	Sale	—	Sep 18	View
From 4	—	—	—	—	May 22, 2013	9.75M	Options	—	May 22	View
From 3	—	—	—	—	May 16, 2013	—	—	—	—	View

tesaro, inc.

Updated: Aug 07, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.20	600.00K	—	—	Aug 07, 2013	2.47M	Disposition	—	Aug 05	View
From 4	-0.67	6.12M	$13.50	—	Jul 05, 2012	3.07M	Buy-Options	—	Jul 03	View
From 3	—	—	—	—	Jun 27, 2012	—	—	—	—	View

transcept pharmaceuticals inc

Updated: Sep 23, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.12	217.23K	$7.24	$1.57M	Sep 23, 2011	1.98M	Purchase	—	Sep 21	View
From 3	—	—	—	—	Sep 22, 2011	1.77M	—	—	—	View

trius therapeutics inc

Updated: Aug 10, 2010

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.74	10.01M	$4.77	—	Aug 10, 2010	3.55M	Buy-Options	—	Aug 06	View
From 3	—	—	—	—	Aug 02, 2010	—	—	—	—	View

enteromedics inc

Updated: Nov 21, 2007

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Nov 21, 2007	1.55M	Options	—	Nov 20	View
From 4	—	187.50K	$8.00	$1.50M	Nov 19, 2007	1.55M	Purchase	—	Nov 15	View
From 3	—	—	—	—	Nov 14, 2007	—	—	—	—	View

corgentech inc

Updated: Feb 18, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.03	70.31K	—	—	Feb 18, 2004	2.10M	Options	—	Feb 18	View
From 3	—	—	—	—	Feb 11, 2004	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions